[HTML][HTML] Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World

LF Oliveira, AO Schubach, MM Martins, SL Passos… - Acta tropica, 2011 - Elsevier
Pentavalent antimonials are first-line drugs for the treatment of the cutaneous form of
American tegumentary leishmaniasis. Second-line drugs include amphotericin B and …

New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment

P Mitropoulos, P Konidas, M Durkin-Konidas - Journal of the American …, 2010 - Elsevier
BACKGROUND: Cutaneous leishmaniasis (CL) has traditionally been underrecognized and
underreported. Improved awareness is warranted as the number of cases has increased as …

Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical …

N Aronson, BL Herwaldt, M Libman… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide

CJ Hodiamont, PA Kager, A Bart… - PLoS neglected …, 2014 - journals.plos.org
Background Leishmaniasis is increasingly reported among travellers. Leishmania species
vary in sensitivity to available therapies. Fast and reliable molecular techniques have made …

[HTML][HTML] Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran

M Mohammadzadeh, F Behnaz, Z Golshan - Journal of infection and public …, 2013 - Elsevier
Glucantime remains the first-line treatment for cutaneous leishmaniasis. In a prospective
study, we evaluated its efficacy and side effects in patients treated in Yazd from 2010 to …

Morinda citrifolia Linn. fruit (Noni) juice induces an increase in NO production and death of Leishmania amazonensis amastigotes in peritoneal macrophages from …

F Almeida-Souza, CSF de Souza, NN Taniwaki… - Nitric Oxide, 2016 - Elsevier
Leishmaniasis is a complex disease that is considered a serious public health problem. Due
to the absence of an effective vaccine and debilitating chemotherapy better therapies are …

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

SG Thacker, IL McWilliams, B Bonnet… - PLoS Neglected …, 2020 - journals.plos.org
Cutaneous leishmaniasis (CL) affects the lives of 0.7–1 million people every year causing
lesions that take months to heal. These lesions can result in disfiguring scars with …

Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro

R Vieira‐Gonçalves, C Pirmez… - International journal …, 2008 - Wiley Online Library
Background American tegumentary leishmaniasis (ATL) caused by Leishmania (Viannia)
braziliensis is endemic in Rio de Janeiro State (RJ), where the disease shows …

Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study

C Oliveira-Ribeiro, MIF Pimentel, RVC Oliveira… - BMC infectious …, 2017 - Springer
Abstract Background Skin ulcers in American cutaneous leishmaniasis (ACL) may heal
spontaneously after months/years. However, few cases may present quick heal even during …

Antimony in plasma and skin of patients with cutaneous leishmaniasis–relationship with side effects after treatment with meglumine antimoniate

DB da Justa Neves, ED Caldas… - Tropical Medicine & …, 2009 - Wiley Online Library
Objective To evaluate the levels of antimony in plasma and skin of patients being treated
with pentavalent antimonials (Glucantime®) and their relationship with side effects. Methods …